| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.40B | +15.2% |
| Gross profit | ¥0.12B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.00B | — |
| Gross margin | 30.8% | Net margin -0.3% |
| Revenue Q/Q | -51.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.28B | 69.2% |
| R&D | ¥0.08B | 20.3% |
| SG&A | ¥0.09B | 22.7% |
| Tax & other | ¥-0.01B | -3.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学 ・ 隆华科技 ・ 佳创视讯 ・ 通光线缆 ・ 兴源环境
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies